Binex to export Remicade biosimilar to Russia
Developed by Johnson & Johnson, Remicade is a blockbuster rheumatoid arthritis drug.
The Korean pharmaceutical firm and Pharmstandard had signed a contract to export the biosimilar to treat ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
